Anonna Dutt

NMC guidelines set limits on medical advertising, discounts, patient testimonials and AI-generated content while allowing doctors to share health information and awareness messages.

Government targets high-cost cancer medicines, including some patented drugs, in a move that could cut MRPs by as much as 70%

Regulating the prices of cancer medicine is essential considering that the cancer burden is on the rise in India and the latest therapies remain out of reach for most.

Steep markups on medicines, medical devices and hospital services are driving up treatment costs. As the government moves to rein in drug margins, the larger challenge is to make private healthcare affordable and transparent without compromising access to care

Govt urges states and UTs to enforce existing rules requiring hospitals and clinics to display service rates, helping patients make informed decisions and reducing billing disputes

Doctors must review all relevant clinical records before digital authentication, keep credentials under their sole control and authenticate only records from healthcare facilities they are associated with

The ban is intended to support broader public health efforts to address concerns associated with early exposure to added sugars, the Union Health Ministry said.

Revised prices shall come into effect from Nov 9, says gazette notification; manufacturers asked to submit revised MRP to pricing authority within 7 days

NavIC, India's satellite-based positioning system, had stopped providing location data after the end of life and failure of atomic clocks, and recent failed launches of replacement satellites. NVS-03's slated launch could change that.

The highest reductions were seen in the chemotherapy medicines Thiotepa for which the price goes down from R80,071 to R7,150 for a 100mg vial. This was followed by the breast cancer immunotherapy drug Pertuzumab for which the prices reduced from Rs 94,951 to Rs 30,593 for a 30mg vial